
Dr. David Kaslow, a former Merck vaccine executive, leaked FDA confidential internal discussions to the press and Big Pharma allies.
By Catholics for Catholics
A high-ranking U.S. Food and Drug Administration official allegedly became a turncoat and leaked secretive information to reporters and industry cronies, weakening the Trump administration’s vaccine plans and probes into possible deaths connected to the mRNA and COVID-19 vaccines.
According to a story by The Defender, Dr. David Kaslow, a previous Merck vaccine executive, supposedly gave away confidential agency talks to the press and Big Pharma allies “to settle internal disputes.”
These discoveries come during a period of unrest for the agency, HHS Secretary Robert F. Kennedy Jr. and the Make America Healthy Again (MAHA) movement after Republicans’ big losses in the midterm elections and strife among MAHA supporters over whether Kennedy has turned his back on MAHA-supported policies.
Investigative journalist Paul D. Thacker, author of The Disinformation Chronicle, told The Defender that his “understanding from talking to sources is that these leaks essentially kneecapped Kennedy’s agenda.”
Kaslow, who joined the FDA during the Biden regime in 2022, has restricted access to safety information, reassigned investigators and obstructed investigations — including the probe into the deaths of at least 10 children that FDA safety officers classified as either probably or possibly related to the COVID-19 vaccine.
In addition, according to the Defender story, two officers implicated in that probe were reassigned from the Center for Biologics Evaluation and Research (CBER), which oversees vaccines.
Drs. Craig Zinderman and Adamma Mba-Jonas, the officers, are currently at the Center for Drug Evaluation and Research, which oversees prescription and over-the-counter drugs.
Kaslow’s alleged leaks also affected agency deliberations earlier this year over whether to approve Moderna’s mRNA flu vaccine.
Kaslow’s dealings may have transgressed confidentiality agreements and the Federal Food, Drug and Cosmetic Act, which prohibits leaking internal FDA deliberations, according to The Disinformation Chronicle. FDA insiders accused Kaslow of treating the rule as “optional.”
So far, the U.S. Department of Health and Human Services (HHS) has taken no disciplinary action against Kaslow and has not commented publicly on whether it has investigated the allegations.
Save and Share This Catholic Patriotic Minute!